GI Dynamics Revenue and Competitors
Estimated Revenue & Valuation
- GI Dynamics's estimated annual revenue is currently $7.4M per year.
- GI Dynamics's estimated revenue per employee is $125,500
- GI Dynamics's total funding is $199.9M.
Employee Data
- GI Dynamics has 59 Employees.
- GI Dynamics grew their employee count by 13% last year.
GI Dynamics's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Finance | Reveal Email/Phone |
2 | Director Clinical Affairs | Reveal Email/Phone |
GI Dynamics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $8.5M | 34 | 3% | N/A | N/A |
#3 | $3M | 12 | -29% | N/A | N/A |
#4 | $5630M | 7477 | -11% | $450M | N/A |
#5 | $4.5M | 18 | 6% | N/A | N/A |
#6 | $7.2M | 57 | 27% | $29.6M | N/A |
#7 | $14.3M | 57 | -12% | N/A | N/A |
#8 | $2.3M | 18 | 6% | $44M | N/A |
#9 | $40.7M | 162 | -1% | N/A | N/A |
#10 | $45.7M | 182 | -5% | N/A | N/A |
What Is GI Dynamics?
GI Dynamics®, Inc. (ASX:GID), is the developer of EndoBarrier®. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. For more information, please visit www.gidynamics.com.
keywords:N/A$199.9M
Total Funding
59
Number of Employees
$7.4M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
GI Dynamics News
Standard Bariatrics, Medtronic, Johnson and Johnson, Aspire Bariatrics, GI Dynamics, TransEnterix, USGI Medical, Apollo Endosurgery,...
Bariatric Surgeries Market Size, Outlook And Forecast | Allergan, Medtronic, Johnson & Johnson, Intuitive Surgical, GI Dynamics, TransEnterix,...
Standard Bariatrics, Medtronic, Johnson and Johnson, Aspire Bariatrics, GI Dynamics, TransEnterix, USGI Medical, Apollo Endosurgery,...
BOSTON and SYDNEY - 22 June 2020- GI Dynamics® Inc. (ASX:GID) ('GID' or the 'Company'), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, announces that it held its Special Meeting of Stockholders on 21 June 2020 and, in accordance with ASX L ...
BOSTON and SYDNEY - 19 June 2020- GI Dynamics® Inc. (ASX:GID) ('GID' or the 'Company'), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce that it has issued a US$750,000 Unsecured Convertible Promissory Note to Crystal ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.3M | 59 | -9% | N/A |
#2 | $9.6M | 59 | 5% | N/A |
#3 | $7.7M | 59 | 119% | N/A |
#4 | $75M | 59 | 23% | $457.8B |
#5 | $3.5M | 59 | -6% | N/A |